|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2002-9-26
|
|
pubmed:abstractText |
The aim of the present study was to confirm the efficacy and tolerability of docetaxel 75 mg/m(2) in a population of Korean patients with advanced gastric cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
pubmed-author:BangYung-JueYJ,
pubmed-author:BoudraaYvaneY,
pubmed-author:DaglishByzanceB,
pubmed-author:HeoDae SeogDS,
pubmed-author:JacquesChristianC,
pubmed-author:KangWon KiWK,
pubmed-author:KangYoon-KooYK,
pubmed-author:KimHugh ChulHC,
pubmed-author:KimNoe KyeongNK,
pubmed-author:KimWon SeogWS,
pubmed-author:ZuberEmmanuelE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-54
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12324575-Adenocarcinoma,
pubmed-meshheading:12324575-Adult,
pubmed-meshheading:12324575-Aged,
pubmed-meshheading:12324575-Drug Administration Schedule,
pubmed-meshheading:12324575-Drug Evaluation,
pubmed-meshheading:12324575-Female,
pubmed-meshheading:12324575-Humans,
pubmed-meshheading:12324575-Male,
pubmed-meshheading:12324575-Middle Aged,
pubmed-meshheading:12324575-Neoplasm Metastasis,
pubmed-meshheading:12324575-Neoplasm Recurrence, Local,
pubmed-meshheading:12324575-Neutropenia,
pubmed-meshheading:12324575-Paclitaxel,
pubmed-meshheading:12324575-Stomach Neoplasms,
pubmed-meshheading:12324575-Taxoids
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial.
|
|
pubmed:affiliation |
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. bangyj@plaza.snu.ac.kr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
